课题基金 / 基金详情

CHARACTERIZATION OF A NOVEL HTLV II CELL LINE

CHARACTERIZATION OF A NOVEL HTLV II CELL LINE
新型 HTLV II 细胞系的表征
批准号:
3792585
负责人:
M RUTA
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

M RUTA的其他基金

相似基金

相关文献

中文摘要
翻译
我们以前从一个再生障碍性患者身上分离出一个细胞系(JR)
英文摘要
We previously isolated a cell line (JR) from a patient with aplastic anemia that produces HTLV II. We are continuing to characterize this cell line and the virus that it produces in order to determine whether its association with aplasia is due to a unique characteristic of this isolate. We analyzed the proteins produced by JR cells by Western blot analysis of JR cells and purified virus and compared these results with standard HTLV II cells and viruses. PCR based sequence analysis of DNA fragments amplified from JR cells were prepared and sequenced. These results show extensive homology between JR and known HTLV II isolates. We are cloning JR virus. Eco RI fragments from genomic DNA of JR cells were prepared and cloned in a lambda vector. The library was screened using subclones of HTLV II Mo viral DNA. Positive clones were identified and partially sequenced. Our results indicate that there is extensive homology between JR and known HTLV II isolates. We are continuing our efforts to clone this virus. We have analyzed sera from other aplastic anemia patients for antibodies to HTLV I/II. One additional reactive sample was detected. We are currently studying whether this person was infected with HTLV.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF A NOVEL HTLV-II CELL LINE
FGF RECEPTOR EXPRESSION IN TUMORS
HTLV-II ELISA AND WESTERN BLOTS
SEROLOGIC MARKERS OF HTLV-I/II INFECTION
海外基金